Shattuck Labs
  • About
    • Overview
    • Our Origins
    • Mission & Vision
    • Management
    • Board of Directors
    • Advisory Board
  • Our Science
    • ARC Platform
    • GADLEN Platform
    • Posters
    • Publications
  • Pipeline
    • Clinical
    • SL-172154 SIRPα-Fc-CD40L
    • Discovery
  • Clinical Trials
    • Overview
    • SL-172154
      • Ovarian Cancer
      • AML & HR-MDS
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • IR Resources
      • FAQS
      • Email Alerts
      • IR & Media Contact
  • Careers
    • Intro to Shattuck
    • Values
    • Benefits
    • Join Our Team
    • Current Openings
  • Contact
    • Locations
    • Contact Us

George Golumbeski, PhD

George Golumbeski has more than 30 years of experience in the biotechnology industry. He has a long history of forging collaborations with companies engaged in “cutting edge” science.  Currently he is dedicated to working to develop young companies. He is a partner at DROIA Ventures. He currently serves on the Board of Directors of Carrick Therapeutics, Sage Therapeutics, and MorphoSys. George was most recently Executive Vice President of Business Development for Celgene, where he was responsible for forging collaborations with biotechnology companies seeking to bring breakthrough medications to people suffering from cancer and chronic inflammation. He holds a PhD in Genetics from the University of Wisconsin-Madison, and conducted his post-doctoral research in molecular biology at the University of Colorado-Boulder. George holds a bachelor’s degree in biology from the University of Virginia

  • About
  • Our Science
  • Pipeline
  • Clinical Trials
  • Investors
  • Careers
  • Contact
© 2023 Shattuck Labs, Inc | Privacy | Terms of Use
logo
  • About
    • Overview
    • Our Origins
    • Mission & Vision
    • Management
    • Board of Directors
    • Advisory Board
  • Our Science
    • ARC Platform
    • GADLEN Platform
    • Posters
    • Publications
  • Pipeline
    • Clinical
    • SL-172154 SIRPα-Fc-CD40L
    • Discovery
  • Clinical Trials
    • Overview
    • SL-172154
      • Ovarian Cancer
      • AML & HR-MDS
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • IR Resources
      • FAQS
      • Email Alerts
      • IR & Media Contact
  • Careers
    • Intro to Shattuck
    • Values
    • Benefits
    • Join Our Team
    • Current Openings
  • Contact
    • Locations
    • Contact Us
  • Follow Us